Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
OBI Pharma Inc (4174 TT)
Watchlist
8
Analysis
Health Care
•
Taiwan
OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
AGP Ltd/PK
•
25 May 2026 18:52
•
Broker
Topline Flash Note: AGP Limited (AGP) – Management Call Key Takeaways
Topline Securities hosted a management call with the leadership team of AGP Limited, wherein the speakers for the session were Mr. Kamran Nasir,...
Topline Securities
Follow
92 Views
Share
bullish
•
AGP Ltd/PK
•
22 May 2026 19:00
•
Broker
Topline Flash Note: AGP Limited (AGP) – Corporate Reorganization; A Step To Unlock Value For Shareholders
The board of AGP has approved a transformative corporate reorganization and integration plan which is subject to further necessary approvals....
Topline Securities
Follow
96 Views
Share
bearish
•
OBI Pharma Inc
•
20 Jan 2023 23:22
Obi Pharma Inc (4174 TT): Inherent Pipeline Risk Has Clouded Near-Term Outlook
As the lead pipeline candidate did not meet primary endpoint in phase 2 trial and developing breast cancer vaccine is a challenging job, phase 3...
Tina Banerjee
Follow
606 Views
Share
bearish
•
OBI Pharma Inc
•
19 Jan 2017 21:58
Allegations Will Distract Management
Since our last Insight The “Fasten Seat Belt Sign” Remains On posted in December, the Shi Lin District Prosecutors Office filed insider trading...
Kemp Dolliver, CFA
339 Views
Share
bearish
•
OBI Pharma Inc
•
10 Dec 2016 11:58
The "Fasten Seat Belt Sign" Remains On
OBI Pharmaceuticals (4174:TT) is a biotechnology company developing treatments for cancer. The shares have declined by 44% since our last Insight...
Kemp Dolliver, CFA
283 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x